
A groundbreaking new blood test allows doctors to map a foetus's genome, potentially eliminating the miscarriage risks associated with amniocentesis.

A groundbreaking new blood test allows doctors to map a foetus's genome, potentially eliminating the miscarriage risks associated with amniocentesis.